Wang, C., Sadun, R., Zhou, W., Miller, K., Palmer, C., Ardoin, S. P., … Cooper, J. (2022). Renal Response Outcomes of North American Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versus NIH Cyclophosphamide Dosing Regimen. In ARTHRITIS & RHEUMATOLOGY (Vol. 74, pp. 1027–1030).

Wang, Christine, Rebecca Sadun, Wenru Zhou, Kristen Miller, Claire Palmer, Stacy P. Ardoin, Christine Bacha, et al. “Renal Response Outcomes of North American Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versus NIH Cyclophosphamide Dosing Regimen.” In ARTHRITIS & RHEUMATOLOGY, 74:1027–30, 2022.

Wang C, Sadun R, Zhou W, Miller K, Palmer C, Ardoin SP, et al. Renal Response Outcomes of North American Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versus NIH Cyclophosphamide Dosing Regimen. In: ARTHRITIS & RHEUMATOLOGY. 2022. p. 1027–30.

Wang, Christine, et al. “Renal Response Outcomes of North American Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versus NIH Cyclophosphamide Dosing Regimen.” ARTHRITIS & RHEUMATOLOGY, vol. 74, 2022, pp. 1027–30.

Wang C, Sadun R, Zhou W, Miller K, Palmer C, Ardoin SP, Bacha C, Hause E, Hui-Yuen J, Ling N, Pereira M, Riebschleger M, Rouster-Stevens K, Sarkissian A, Shalen J, Soulsby W, Twilt M, Wu E, Lewandowski L, Wenderfer S, Cooper J. Renal Response Outcomes of North American Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versus NIH Cyclophosphamide Dosing Regimen. ARTHRITIS & RHEUMATOLOGY. 2022. p. 1027–1030.